Early interactions procedures with regulators to support medicines’ development and mainly innovative medicines have been established:
- At the European Union level, where the procedures have been set up by the European Medicines Agency. Please see sub-entry: Support for innovative medicines’ development at the EMA level.
- At national level where they have been set up by the national competent authorities mainly the national medicines agencies. Please see sub-entry: Support for innovative medicines’ development at the national level (page in development).
- Support mechanisms that involve several regulators also exists. Please see sub-entry: Support for innovative medicines’ development by several regulators (page in development).